KUMIAI CHEMICAL INDUSTRY CO.,LTD. FY2026 Q2 Earnings Report

Financial Highlights

• Net Sales: ¥102.92B
• Operating Income: ¥10.46B
• Net Income: ¥8.42B
• EPS: ¥72.63

Income Statement

Balance Sheet

Profitability Ratios

Year-over-Year Comparison

Share Information

Dividend Information

Segment Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

Verdict: Solid Q2 with broad-based profit growth, margin expansion, and strong outperformance versus full-year guidance. Revenue rose 7.0% YoY to 1,029.19, with operating income up 10.8% YoY to 104.64 and net income up 39.4% YoY to 87.48. Gross profit increased to 223.05, lifting gross margin by roughly 5 bps YoY to 21.7%. Operating margin improved by about 36 bps to 10.2% on disciplined SG&A and favorable mix. Net margin expanded by approximately 198 bps to 8.5%, supported by higher ordinary income and equity-method gains. Ordinary income jumped 66.0% YoY to 137.63, reflecting 2.32 in equity-method income and other non-operating gains. Segment performance was led by Agrichemicals, with sales +6.6% and operating income +8.7% YoY; Chemicals grew faster on both top line (+16.2%) and operating income (+38.2%). Balance sheet remains conservative: current ratio 209%, D/E 0.61x, and interest coverage 31x. That said, the liability mix is short-term heavy (short-term debt ratio 81.7%), elevating refinancing risk. Working capital intensity is high: DSO 208 days, DIO 342 days, and CCC 439 days, indicating cash conversion headwinds despite earnings strength. Extraordinary losses of 17.02, including a 5.14 impairment tied to a chlorination business and restructuring, weighed on profit before tax but did not derail net profit growth. DuPont shows ROE at 5.5%, with margin gains offset by low asset turnover (0.397x). Progress against guidance is well ahead: sales at 63.5% (vs 50% typical), operating income at 145% of the full-year plan, ordinary income at 126%, and net income at 137%, indicating a likely upward bias to forecasts absent H2 headwinds. Goodwill and intangibles are minimal relative to equity (0.8% and 0.9% of assets, respectively), limiting impairment risk. Dividend payout is conservative at 15.2% for the interim, with the planned full-year DPS of 14 implying a roughly mid-20% payout, comfortably covered by earnings. Overall, the quarter demonstrates healthy operating leverage and segment execution, but cash conversion and short-term funding concentration warrant close monitoring.

Profitability Analysis

ROE (5.5%) = Net Profit Margin (8.5%) × Asset Turnover (0.397x) × Financial Leverage (1.61x). The biggest YoY driver was net profit margin, which expanded by about 198 bps, while operating margin improved ~36 bps to 10.2% and gross margin edged up ~5 bps to 21.7%. Ordinary income strength (+66% YoY) came from higher equity-method income and other non-operating improvements, boosting the interest burden metric (EBT/EBIT >1) as financial income outweighed interest costs. Asset turnover remains subdued at 0.397x, reflecting a working capital-heavy model with long DSO and DIO, which drags on capital efficiency despite profit gains. Financial leverage at 1.61x is moderate and stable, contributing modestly to ROE. The margin improvements look partly sustainable given segment operating gains and SG&A discipline (SG&A +4.3% vs revenue +7.0%), implying positive operating leverage. Equity-method income (2.32) is supportive but can be volatile; we view it as semi-recurring given the portfolio nature. Key watchpoint: if SG&A growth accelerates above sales growth or if extraordinary charges recur, the margin trajectory could stall.

Growth Assessment

Top-line growth of 7.0% was led by Agrichemicals (+6.6%) and Chemicals (+16.2%), with balanced contribution from volume/mix and pricing. Operating income rose 10.8%, outpacing sales on operating leverage, while ordinary income surged 66.0% on stronger non-operating items and equity-method gains. Net income grew 39.4% despite 17.02 in extraordinary losses, underscoring resilient core earnings. Segment margins improved notably in Chemicals (to 7.8%) and remained robust in Agrichemicals (11.8%). With year-to-date progress far ahead of full-year guidance across all profit lines, execution appears ahead of plan; barring H2 commodity, FX, or demand headwinds, upward forecast risk is present. The investment securities balance (417.43) and equity-method income suggest portfolio earnings support. Working capital remains a headwind to growth quality due to slow cash conversion, and elevated receivables growth (+50.2% YoY) requires continued credit discipline.

Financial Health

Liquidity is strong: current ratio 209%, quick ratio 146.6%, and working capital 855.94. Solvency is conservative with D/E 0.61x, Debt/Capital 25.0%, and interest coverage 31.05x, indicating ample headroom. However, the short-term debt ratio is high at 81.7%, and cash/short-term debt is 0.63x, signaling refinancing and rollover dependence; we flag a maturity mismatch risk, though it is mitigated by strong current assets (1,638.49) comfortably exceeding current liabilities (782.55). Notable YoY balance sheet shifts: accounts receivable +50.2% to 585.27 (credit risk and collection timing), cash +26.3% to 277.74 (liquidity buffer), and long-term loans -31.5% to 98.07 (terming out limited; overall shift toward short-term funding). Investment securities stand at 417.43 (16.1% of assets), providing valuation-sensitive capital and potential liquidity. No off-balance sheet obligations were disclosed.

Notable B/S Changes

Accounts Receivable: +195.6 (+50.2%) - Aggressive sales/extended terms; elevates credit and collection risk. Long-term Loans: -45.2 (-31.5%) - Reduced long-term funding; increases reliance on short-term borrowings. Cash & Deposits: +57.9 (+26.3%) - Strengthened liquidity buffer amid higher short-term debt.

Cash Flow Quality

Operating cash conversion is pressured: DSO 208 days, DIO 342 days, and CCC 439 days signal slow monetization of earnings. Receivables rose 50.2% YoY, outpacing sales growth, which raises collection and credit concentration risk. Inventory contracted YoY, which is a positive directional datapoint for cash release, but absolute DIO remains elevated. Equity-method income contributes meaningfully to ordinary income but is non-cash, which reduces immediate OCF conversion. Given these signals, we see a risk that OCF trails net income in the period and recommend close monitoring of receivables collections, customer terms, and inventory turns to sustain dividend and capex outlays.

Dividend Sustainability

Interim DPS is 10 JPY, implying a 15.2% payout ratio on H1 earnings. Full-year plan calls for 14 JPY DPS versus forecast EPS of 53.15, implying a payout ratio of roughly the mid-20% range, well within sustainable levels. Balance sheet strength (current ratio 209%, D/E 0.61x) supports dividend capacity. While working capital intensity could suppress OCF near term, the low payout ratio provides a cushion. We expect policy continuity with potential for incremental returns if cash conversion improves and profit outperformance persists.

Risk Assessment

Business risks include Demand variability in core agrichemicals tied to planting cycles and weather, Commodity and input price volatility impacting gross margin, FX fluctuation risk affecting overseas sales and translation, Execution risk in restructuring of underperforming chemical sub-businesses.

Financial risks include Refinancing risk due to short-term debt ratio at 81.7% and cash/STD at 0.63x, Working capital intensity with DSO 208 days and DIO 342 days elevating CCC to 439 days, Capital efficiency constraint with ROIC at 3.8%, below cost of capital benchmarks, Receivables growth (+50.2% YoY) increasing credit exposure.

Key concerns include ⚠️ REFINANCING_RISK: Short-term debt ratio of 81.7% indicates reliance on short-dated funding; while common in trading-heavy businesses, it heightens rollover exposure. Impact: potential interest cost volatility and liquidity sensitivity if credit conditions tighten., ⚠️ CAPITAL_EFFICIENCY: ROIC at 3.8% is below the 5% threshold; for chemicals/agri-chem peers, sub-5% signals underutilized assets. Impact: constrains valuation multiples and raises pressure for asset turnover and mix improvements., ⚠️ HIGH_RECEIVABLE_DAYS: DSO at 208 days is significantly above the <60-day benchmark, pointing to slow collections and possible customer concentration. Impact: weaker OCF/NI conversion and higher credit risk., ⚠️ HIGH_INVENTORY_DAYS: DIO at 342 days (and elevated alternate reading) reflects slow-moving stock and long production/distribution cycles. Impact: working capital drag and potential obsolescence/write-down risk if demand softens., ⚠️ LONG_CCC: A 439-day CCC is far above the 120-day warning line, underscoring cash conversion weakness. Impact: limits financial flexibility and could force higher short-term borrowing..

Investment Implications

Key takeaways include Beat-like H1 with sales +7.0%, OP +10.8%, NI +39.4%, and broad margin expansion, Ordinary income strength (137.63) supported by equity-method income (2.32) and non-operating gains, Guidance tracking well ahead: OP at 145% of full-year plan at Q2, Balance sheet conservative (current ratio 209%, D/E 0.61x) but funding skewed to short-term debt (81.7%), Cash conversion is the principal weak point (DSO 208, DIO 342, CCC 439), Extraordinary losses (17.02) include impairment (5.14) tied to chlorination and restructuring; limited recurring impact expected, Low goodwill/intangibles reduce future impairment risk; investment securities (417.43) provide optionality.

Metrics to watch include OCF/Net Income and receivables collection pace (DSO trajectory), Inventory turns and DIO normalization, Short-term debt rollover profile and cost of debt trends, Equity-method income stability, Segment margins, especially Chemicals sustainability after strong YoY improvement.

Regarding relative positioning, Within Japanese agri-chem/chemicals peers, profitability this half is competitive with a solid 10.2% operating margin and strong ordinary income, while capital efficiency (ROIC 3.8%, asset turnover 0.397x) and cash conversion lag best-in-class operators. Balance sheet strength offers resilience, but working capital and refinancing concentration keep risk higher than asset-light peers.